Endocrinology
Diabetes Mellitus, Use of Glycated Hemoglobin and Microalbuminuria
July 2003
Clinical Focus*
Glycemic Control
- What is the risk relationship between glycated hemoglobin and the subsequent risk of microvascular diabetic complications (retinopathy, nephropathy, neuropathy)?
- What is the risk relationship between glycated hemoglobin and the subsequent risk of macrovascular diabetic complications (coronary artery disease, cerebrovascular disease, peripheral arterial disease)?
Urine Albumin
- What is the risk relationship between microalbuminuria and renal function?
- What is the risk relationship between microalbuminuria and cardiovascular disease and death?
*Addressed in the summary or evidence report.
Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus
Summary (Publication No. 03-E048, July 2003)
Evidence Report (File Download) (Publication No. 04-E001, October 2003)
EPC: Johns Hopkins University
Topic Nominator: American Association of Clinical Chemistry
Return to Quick Menu: Evidence Report Topics
Return to Evidence-based Practice